Evidence map›Paper›PMID 41479126›Full record

ArticleJournal of pediatric gastroenterology and nutrition2026

Clinical, manometric, genetic, and histologic associations in pediatric intestinal pseudo-obstruction: A case series.

Sharon Wolfson, Myra Butrviengpunt, Naomi Tjaden, Alain J Benitez, Archana S Kota, Jennifer Webster, Prasanna Kapavarapu, Hayat Mousa, Robert O Heuckeroth

Abstract read
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sharon WolfsonDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-5442-4533
Myra ButrviengpuntTouro College of Osteopathic Medicine, Middletown, New York, USA.
Naomi TjadenDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Alain J BenitezDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Archana S KotaDepartment of Pediatrics, Division of Pediatric Gastroenterology, New York University Grossman School of Medicine, New York, New York, USA.
Jennifer WebsterDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Prasanna KapavarapuDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Hayat MousaDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Robert O HeuckerothDivision of Pediatric Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

Biochemical and cellular mechanisms linking actin mutations to visceral myopathyR01DK128282 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI HEUCKEROTH, ROBERT O · 2021 to 2025
$3.5M
Training Program in the Genetic Basis of Pediatric Gastrointestinal DisordersT32DK101371 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBERT O HEUCKEROTH, Judith Rachel Kelsen · 2014 to 2026
$2.5M
Defining non-genetic mechanisms that prevent death in a Hirschsprung disease mouse modelR01DK129691 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI HEUCKEROTH, ROBERT O · 2021 to 2024
$2.3M
Mechanistic human studies to prevent Hirschsprung-associated enterocolitisR01DK141691 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI ROBERT O HEUCKEROTH · 2025 to 2026
$1.4M
American Gastroenterology Association Research Scholar Award AGA2025-13-06American Neurogastroenterology and Motility Society (ANMS) Discovery Grants Program (NT)American Neurogastroenterology and Motility Society Discovery Grants ProgramChildren's Hospital of Philadelphia, Frontier Program for Precision Diagnosis and Therapy for Pediatric Motility DisordersFrontier Program for Precision Diagnosis and Therapy for Pediatric Motility Disorders HFRNT21002Frontier Program for Precision Diagnosis and Therapy for Pediatric Motility Disorders RFRNT21002Irma and Norman Braman EndowmentNIDDK NIH HHS R01 DK128282NIDDK NIH HHS R01 DK141691NIDDK NIH HHS T32 DK101371NIH HHS L40DK134022NIH HHS R01 DK129691North American Society for Pediatric Gastroenterology, Hepatology and NutritionNorth American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)Reckitt Mead Johnson Nutrition Research Young Investigator Development AwardSuzi and Scott Lustgarten Center EndowmentThe Children's Hospital of Philadelphiathe Irma and Norman Braman Endowment (ROH), and the Suzi and Scott Lustgarten Center Endowment (ROH)
6 · The paper itself

Abstract

objectivesPediatric intestinal pseudo-obstruction (PIPO) is a severe bowel motility disorder characterized by impaired propulsion of gastrointestinal contents without mechanical obstruction. PIPO encompasses congenital and acquired disorders, including neuropathies, myopathies, and mesenchymopathies. PIPO presents with abdominal distension, bilious vomiting, and severe constipation. Diagnosis is based on objective measures of neuromuscular dysfunction, dilated bowel on imaging, parenteral and/or enteral nutrition dependence, and genetic or metabolic testing. Antroduodenal manometry permits objective assessment of proximal bowel neuromuscular function. Genetic testing is increasingly valuable although causes of PIPO often remain incompletely defined. Understanding genotype-phenotype correlations is essential for clarifying disease mechanisms and guiding therapies. This study aimed to characterize the clinical and genetic profiles of children with PIPO, utilizing manometric data for subtype classification.

methodsA retrospective chart review was conducted at a tertiary care pediatric medical center, with inclusion criteria of PIPO diagnosis, completed manometry testing, and genetic evaluation.

resultsNineteen children met inclusion criteria. Antroduodenal manometry classified 59% as neuropathic, 35% as myopathic, and one with mixed neuropathic and myopathic dysfunction. Genetic testing revealed pathogenic ACTG2 mutations in all myopathic cases, while neuropathic PIPO exhibited more genetic variability. Histopathology was inconsistent and often nonspecific. Therapeutic approaches focused on nutritional support and promotility agents, with surgical intervention more common in myopathic cases.

conclusionsThis study highlights the association of ACTG2 mutations with a myopathic phenotype, and genetic diversity in neuropathic PIPO, emphasizing the need for further research to improve phenotyping to enhance diagnosis and treatment.

Indexed as

Intestinal Pseudo-ObstructionActinsAdolescentChildChild, PreschoolFemaleGenetic Association StudiesGenetic TestingHumansInfantMaleManometryMutationRetrospective StudiesACTG2 protein, humanActinsACTG2chronic intestinal pseudo‐obstructionintestinal myopathyintestinal neuropathy

Identifiers

PMID41479126
PMCPMC12964506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.